These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


630 related items for PubMed ID: 29873288

  • 1. Improvement of oral efficacy of Irinotecan through biodegradable polymeric nanoparticles through in vitro and in vivo investigations.
    Ahmad N, Alam MA, Ahmad R, Umar S, Jalees Ahmad F.
    J Microencapsul; 2018 Jun; 35(4):327-343. PubMed ID: 29873288
    [Abstract] [Full Text] [Related]

  • 2. Biodegradable polymeric nanoparticles for oral delivery of epirubicin: In vitro, ex vivo, and in vivo investigations.
    Tariq M, Alam MA, Singh AT, Iqbal Z, Panda AK, Talegaonkar S.
    Colloids Surf B Biointerfaces; 2015 Apr 01; 128():448-456. PubMed ID: 25769281
    [Abstract] [Full Text] [Related]

  • 3. Daunorubicin oral bioavailability enhancement by surface coated natural biodegradable macromolecule chitosan based polymeric nanoparticles.
    Ahmad N, Ahmad R, Alam MA, Ahmad FJ, Amir M, Pottoo FH, Sarafroz M, Jafar M, Umar K.
    Int J Biol Macromol; 2019 May 01; 128():825-838. PubMed ID: 30690115
    [Abstract] [Full Text] [Related]

  • 4. Preparation and characterization of surface-modified PLGA-polymeric nanoparticles used to target treatment of intestinal cancer.
    Ahmad N, Alam MA, Ahmad R, Naqvi AA, Ahmad FJ.
    Artif Cells Nanomed Biotechnol; 2018 Mar 01; 46(2):432-446. PubMed ID: 28503995
    [Abstract] [Full Text] [Related]

  • 5. Preparation and in vitro evaluation of thienorphine-loaded PLGA nanoparticles.
    Yang Y, Xie XY, Mei XG.
    Drug Deliv; 2016 Mar 01; 23(3):787-93. PubMed ID: 24870204
    [Abstract] [Full Text] [Related]

  • 6. Mechanisms of chitosan-coated poly(lactic-co-glycolic acid) nanoparticles for improving oral absorption of 7-ethyl-10-hydroxycamptothecin.
    Guo M, Rong WT, Hou J, Wang DF, Lu Y, Wang Y, Yu SQ, Xu Q.
    Nanotechnology; 2013 Jun 21; 24(24):245101. PubMed ID: 23702815
    [Abstract] [Full Text] [Related]

  • 7. Irinotecan and 5-fluorouracil-co-loaded, hyaluronic acid-modified layer-by-layer nanoparticles for targeted gastric carcinoma therapy.
    Gao Z, Li Z, Yan J, Wang P.
    Drug Des Devel Ther; 2017 Jun 21; 11():2595-2604. PubMed ID: 28919710
    [Abstract] [Full Text] [Related]

  • 8. Novel flavonoid-based biodegradable nanoparticles for effective oral delivery of etoposide by P-glycoprotein modulation: an in vitro, ex vivo and in vivo investigations.
    Fatma S, Talegaonkar S, Iqbal Z, Panda AK, Negi LM, Goswami DG, Tariq M.
    Drug Deliv; 2016 Jun 21; 23(2):500-11. PubMed ID: 24937381
    [Abstract] [Full Text] [Related]

  • 9. Surface decorated nanoparticles as surrogate carriers for improved transport and absorption of epirubicin across the gastrointestinal tract: Pharmacokinetic and pharmacodynamic investigations.
    Tariq M, Alam MA, Singh AT, Panda AK, Talegaonkar S.
    Int J Pharm; 2016 Mar 30; 501(1-2):18-31. PubMed ID: 26812610
    [Abstract] [Full Text] [Related]

  • 10. Alpha-tocopheryl polyethylene glycol succinate-emulsified poly(lactic-co-glycolic acid) nanoparticles for reversal of multidrug resistance in vitro.
    Wang Y, Guo M, Lu Y, Ding LY, Ron WT, Liu YQ, Song FF, Yu SQ.
    Nanotechnology; 2012 Dec 14; 23(49):495103. PubMed ID: 23149859
    [Abstract] [Full Text] [Related]

  • 11. Novel docetaxel chitosan-coated PLGA/PCL nanoparticles with magnified cytotoxicity and bioavailability.
    Badran MM, Alomrani AH, Harisa GI, Ashour AE, Kumar A, Yassin AE.
    Biomed Pharmacother; 2018 Oct 14; 106():1461-1468. PubMed ID: 30119220
    [Abstract] [Full Text] [Related]

  • 12. SN38 polymeric nanoparticles: in vitro cytotoxicity and in vivo antitumor efficacy in xenograft balb/c model with breast cancer versus irinotecan.
    Sepehri N, Rouhani H, Tavassolian F, Montazeri H, Khoshayand MR, Ghahremani MH, Ostad SN, Atyabi F, Dinarvand R.
    Int J Pharm; 2014 Aug 25; 471(1-2):485-97. PubMed ID: 24879937
    [Abstract] [Full Text] [Related]

  • 13. Preparation, characterization, and in vitro and in vivo investigation of chitosan-coated poly (d,l-lactide-co-glycolide) nanoparticles for intestinal delivery of exendin-4.
    Wang M, Zhang Y, Feng J, Gu T, Dong Q, Yang X, Sun Y, Wu Y, Chen Y, Kong W.
    Int J Nanomedicine; 2013 Aug 25; 8():1141-54. PubMed ID: 23658482
    [Abstract] [Full Text] [Related]

  • 14. Enhanced bioavailability and intestinal uptake of Gemcitabine HCl loaded PLGA nanoparticles after oral delivery.
    Joshi G, Kumar A, Sawant K.
    Eur J Pharm Sci; 2014 Aug 18; 60():80-9. PubMed ID: 24810394
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Improved mucoadhesion and cell uptake of chitosan and chitosan oligosaccharide surface-modified polymer nanoparticles for mucosal delivery of proteins.
    Dyawanapelly S, Koli U, Dharamdasani V, Jain R, Dandekar P.
    Drug Deliv Transl Res; 2016 Aug 18; 6(4):365-79. PubMed ID: 27106502
    [Abstract] [Full Text] [Related]

  • 17. Effects of borneol on the pharmacokinetics of 9-nitrocamptothecin encapsulated in PLGA nanoparticles with different size via oral administration.
    Ru G, Han L, Qing J, Sheng J, Li R, Qiu M, Wang J.
    Drug Deliv; 2016 Nov 18; 23(9):3417-3423. PubMed ID: 27174642
    [Abstract] [Full Text] [Related]

  • 18. Levofloxacin loaded chitosan and poly-lactic-co-glycolic acid nano-particles against resistant bacteria: Synthesis, characterization and antibacterial activity.
    Hayee R, Iqtedar M, Albekairi NA, Alshammari A, Makhdoom MA, Islam M, Ahmed N, Rasool MF, Li C, Saeed H.
    J Infect Public Health; 2024 May 18; 17(5):906-917. PubMed ID: 38569270
    [Abstract] [Full Text] [Related]

  • 19. Bioavailability enhancement, Caco-2 cells uptake and intestinal transport of orally administered lopinavir-loaded PLGA nanoparticles.
    Joshi G, Kumar A, Sawant K.
    Drug Deliv; 2016 Nov 18; 23(9):3492-3504. PubMed ID: 27297453
    [Abstract] [Full Text] [Related]

  • 20. N-trimethyl chitosan chloride-coated PLGA nanoparticles overcoming multiple barriers to oral insulin absorption.
    Sheng J, Han L, Qin J, Ru G, Li R, Wu L, Cui D, Yang P, He Y, Wang J.
    ACS Appl Mater Interfaces; 2015 Jul 22; 7(28):15430-41. PubMed ID: 26111015
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 32.